We aimed to investigate the incidence and clinical relevance of the various AKI phenotypes, utilizing glomerular function and NGAL, as tubular injury marker, for AKI diagnosis, in a cohort of myocardial infarction patients treated percutaneous coronary intervention (PCI). The gene discussed is LCN2; the disease is acute kidney injury.